Medicine & Life Sciences
Parkinson Disease
100%
Multiple Sclerosis
62%
Alzheimer Disease
60%
Autoimmune Experimental Encephalomyelitis
44%
Cognitive Dysfunction
42%
Dementia
39%
Gait
38%
Stroke
36%
Brain
36%
Levodopa
33%
T-Lymphocytes
26%
Blood-Brain Barrier
25%
Therapeutics
24%
Cognition
23%
Central Nervous System
21%
Cerebrospinal Fluid
20%
Parkinsonian Disorders
19%
Biomarkers
17%
Neurons
17%
Seizures
16%
Peptides
16%
Placebos
15%
Sleep
15%
T-Cell Antigen Receptor
14%
Clinical Trials
14%
Postural Balance
14%
Myelin Basic Protein
14%
Accidental Falls
14%
Freezing
14%
Randomized Controlled Trials
13%
Proteins
12%
Mental Status and Dementia Tests
12%
Amyloid
12%
Genes
12%
Brain Neoplasms
12%
Pyoderma Gangrenosum
12%
Veterans
12%
Caregivers
12%
Ferrosoferric Oxide
11%
Walking
11%
Magnetic Resonance Imaging
11%
Neurodegenerative Diseases
11%
Health
11%
Pathology
10%
Population
10%
Memory
10%
Technology
10%
Mutation
10%
White Matter
10%
Epilepsy
10%
Traumatic Brain Injury
10%
Equipment and Supplies
9%
Axons
9%
Drug Therapy
9%
Elderly
9%
Brain Concussion
9%
Electroencephalography
9%
Safety
9%
Deep Brain Stimulation
9%
Thioctic Acid
9%
Myelin Sheath
9%
Thrombectomy
8%
Encephalomyelitis
8%
Ligands
8%
Mindfulness
8%
Pharmaceutical Preparations
8%
Amyotrophic Lateral Sclerosis
8%
Synucleins
8%
Spinal Cord
8%
Dopamine
8%
Lymphoma
7%
Neoplasms
7%
Centella
7%
Nervous System
7%
Manihot
7%
Health Care Outcome Assessment
7%
Walking Speed
7%
Brain-Computer Interfaces
7%
Neuroimaging
7%
Neurology
7%
Education
7%
Infarction
7%
Dopaminergic Neurons
7%
Meditation
7%
Disease Progression
7%
Pantothenate Kinase-Associated Neurodegeneration
7%
Estrogens
7%
Dyskinesias
7%
Regulatory T-Lymphocytes
7%
Rehabilitation
7%
Eye
6%
Fatigue
6%
Atrophy
6%
Animals
6%
Depression
6%
Aged, 80 and over
6%
Systematic Reviews
6%
Inflammation
6%
Healthy Volunteers
6%
Quality of Life
6%